WallStreetZenWallStreetZen

NASDAQ: LFMD
Lifemd Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LFMD

Based on 5 analysts offering 12 month price targets for Lifemd Inc

Min Forecast
$7.00-18.79%
Avg Forecast
$11.00+27.61%
Max Forecast
$15.00+74.01%

Should I buy or sell LFMD stock?

Based on 5 analysts offering ratings for Lifemd Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LFMD's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LFMD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LFMD stock forecasts and price targets.

LFMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-12
lockedlocked$00.00+00.00%2025-03-11
lockedlocked$00.00+00.00%2025-01-08
lockedlocked$00.00+00.00%2024-12-10
lockedlocked$00.00+00.00%2024-12-04

1 of 1

Forecast return on equity

Is LFMD forecast to generate an efficient return?

Company
N/A
Industry
10.28%
Market
72.98%

Forecast return on assets

Is LFMD forecast to generate an efficient return on assets?

Company
-2.46%
Industry
9.12%
LFMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LFMD earnings per share forecast

What is LFMD's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.06

LFMD revenue forecast

What is LFMD's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$268.0M+26.12%
Avg 2 year Forecast
$289.8M+36.41%
LFMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LFMD revenue growth forecast

How is LFMD forecast to perform vs Health Information Services companies and vs the US market?

Company
26.12%
Industry
9.71%
Market
58.92%
LFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LFMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LFMD vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
LFMD$8.62$11.00+27.61%Strong Buy
TBRG$26.05$28.50+9.40%Buy
CTEV$23.02$15.75-31.58%Hold
DH$2.77$3.67+32.38%Sell
SPOK$14.42N/AN/A
View Top Health Information Service Stocks

Lifemd Stock Forecast FAQ

Is Lifemd Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: LFMD) stock is to Strong Buy LFMD stock.

Out of 5 analysts, 3 (60%) are recommending LFMD as a Strong Buy, 1 (20%) are recommending LFMD as a Buy, 1 (20%) are recommending LFMD as a Hold, 0 (0%) are recommending LFMD as a Sell, and 0 (0%) are recommending LFMD as a Strong Sell.

If you're new to stock investing, here's how to buy Lifemd stock.

What is LFMD's earnings growth forecast for 2025-2025?

(NASDAQ: LFMD) Lifemd's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 43.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.53%.

Lifemd's earnings in 2025 is -$21,987,982.

In 2025, LFMD is forecast to generate $2,675,021 in earnings, with the lowest earnings forecast at -$4,458,369 and the highest earnings forecast at $9,808,411.

What is LFMD's revenue growth forecast for 2025-2026?

(NASDAQ: LFMD) Lifemd's forecast annual revenue growth rate of 26.12% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.92%.

Lifemd's revenue in 2025 is $212,453,838.On average, 2 Wall Street analysts forecast LFMD's revenue for 2025 to be $11,946,199,200, with the lowest LFMD revenue forecast at $11,930,594,909, and the highest LFMD revenue forecast at $11,961,803,490.

In 2026, LFMD is forecast to generate $12,920,352,782 in revenue, with the lowest revenue forecast at $12,920,352,782 and the highest revenue forecast at $12,920,352,782.

What is LFMD's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: LFMD) forecast ROA is -2.46%, which is lower than the forecast US Health Information Services industry average of 9.12%.

What is LFMD's Price Target?

According to 5 Wall Street analysts that have issued a 1 year LFMD price target, the average LFMD price target is $11.00, with the highest LFMD stock price forecast at $15.00 and the lowest LFMD stock price forecast at $7.00.

On average, Wall Street analysts predict that Lifemd's share price could reach $11.00 by Mar 12, 2026. The average Lifemd stock price prediction forecasts a potential upside of 27.61% from the current LFMD share price of $8.62.

What is LFMD's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: LFMD) Lifemd's current Earnings Per Share (EPS) is -$0.53. In 2025, LFMD's EPS is forecast to hit $0.06 (min: -$0.10, max: $0.22).

What is LFMD's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: LFMD) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.